Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients

Psychiatric Quarterly

Volumn 80, Issue 3, 2009, Pages 131-141

  Kumar, Virender ^a   Encinosa, William ^b  

^a WESTAT   (United States)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

Antidepressants; HIV drugs; Medication adherence

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DRINKING BEHAVIOR; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG USE; EMOTION; EMPLOYMENT; FEMALE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT COMPLIANCE; REGRESSION ANALYSIS; SELF REPORT; SOCIAL SUPPORT; STATISTICAL MODEL; WELLBEING;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MENTAL HEALTH; MIDDLE AGED; MODELS, STATISTICAL;

EID: 69049108661     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-009-9100-z     Document Type: Article

References (28)

1. DR Bangsberg 2006 Less than 95% adherence to nonnucleoside reverse transcriptase inhibitor therapy can lead to viral suppression Clinical Infectious Disease 43 939 941 10.1086/507526
2. L Osterberg T Blaschke 2005 Adherence to medication New England Journal of Medicine 353 487 497 10.1056/NEJMra050100
3. M Chesney 2003 Adherence to HAART regimens AIDS Patient Care 17 169 177 10.1089/108729103321619773
4. DL Paterson S Swindells J Mohr M Brester EN Vergis C Squier, et al. 2000 Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 1 21 30
5. JA Ciesla JE Roberts 2001 Meta-analysis of the relationship between HIV infection and risk for depressive disorders American Journal of Psychiatry 158 725 730 10.1176/appi.ajp.158.5.725
6. M Mugavero J Ostermann K Whetten 2006 et al. Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events AIDS Patient Care STDs 20 418 428 10.1089/apc.2006.20.418
7. A Ammassari A Antinori MS Aloisi, et al. 2004 Depressive symptoms neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons Psychosomatics 45 394 402 10.1176/appi.psy.45.5.394
8. AE Castaneda J Suvisaari M Marttunen J Perala SI Saarni, et al. 2008 Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity Journal of Affective Disorders 110 1-2 36 45 10.1016/j.jad.2007.12. 239
9. D Paleacu A Shutzman N Giladi T Herman ES Simon, et al. 2007 Effects of pharmacological therapy on gait, congnitive functions in depressed patients Clinical Neuropharmacology 30 2 63 71 10.1097/01.wnf.0000240949.41691.95
10. M-P Austin P Mitchell GM Goodwin 2001 Congnitive deficits in depression British Journal of Psychiatry 178 200 206 10.1192/bjp.178.3.200
11. CH Hinkin DH Hardy KI Mason SA Castellon RS Durvasula MN Lam, et al. 2004 Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse AIDS 18 Suppl 1 S19 S25 10.1097/00002030-200401001- 00004
12. D Waldrop-Valverde RL Ownby FL Wilkie A Mack M Kumar, et al. 2006 Neurocognitive Aspects of Medication adherence in HIV-positive injecting drug users AIDS and Behavior May 10 3 287 297 10.1007/s10461-005-9062-6
13. MA Chesney 2006 HIV The elusive gold standard: Future perspectives for HIV adherence assessment and intervention J Acquir Immune Defic Synd 43 Suppl 1 S149 S155 10.1097/01.qai.0000243112.91293.26
14. GH Friedland 2006 HIV medication adherence. The intersection of biomedicatl, behavioral, and social science research and clinical practice J Acquir Immune Defic Synd 43 Suppl 1 S3 S9
15. CH Hinkin SA Castellon RS Durvasula, et al. 2002 Medication Adherence among HIV + adults Neurology 59 12 1944 1950
16. S Himelhoch DR Medoff 2005 Efficacy of antidepressant medication among HIV-positive individuals with depression: A systematic review and meta analysis AIDS Patient Care and STDs 19 12 813 822 10.1089/apc.2005.19.813
17. M Dalessandro CM Conti F Gambi K Falasca R Doyle, et al. 2007 Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients Journal of Clinincal Psychopharmacology 27 1 58 61 10.1097/JCP.0b013e31802f0dd1
18. J Walkup W Wei U Sambamoorthi S Crystal 2008 Antidepressant treatment and adherence to Combination antiretroviral therapy among patients with AIDS and diagnosed depression Pyschiatric Quarterly 79 43 53 10.1007/s11126-007-9055-x
19. MA Horberg MJ Silverberg LB Hurley WJ Towner DB Klein, et al. 2008 Effects of depression and selective serotonine reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients Journal of Aquired Immune Deficiency Syndrome 47 3 384 390
20. S Martin PL Wolters SK Calabrese MA Toledo-Tamula LV Wood, et al. 2007 The Antiretroviral Regimen Complexity Index: A Novel Method of Quantifying Regimen Complexity J Acquir Immune Deficiency Syndr 45 5 535 544 10.1097/QAI.0b013e31811ed1f1
21. SA Bozzette SH Berry N Duan MR Frankel AA Leibowitz D Lefkowitz, et al. 1998 The care of HIV-infected adults in the United States, HIV Cost and Services Utilization Study Consortium N Engl J Med 339 26 1897 1904 10.1056/ NEJM199812243392606
22. MR Frankel MF Shapiro N Duan SC Morton SH Berry JA Brown, et al. 1999 National probability samples in studies of low-prevalence diseases Part II Designing and implementing the HIV cost and services utilization study sample Health Serv Res 34 5 Pt 1 969 992
23. MF Shapiro ML Berk SH Berry CA Emmons LA Athey DC Hsia, et al. 1999 National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study Health Serv Res 34 5 Pt 1 951 968
24. United States Department of Agriculture & United States Department of Health and Human Services: In: United States Department of Health and Human Services & United States Department of Agriculture (Eds.), Chapter 9-Alcoholic beverages. Dietary Guidelines for Americans. Washington, DC: US Government Printing Office pp. 43-46, 2005
25. National Institute of Alcohol Abuse and Alcoholism: NIAAA council approves definition of binge drinking [Electronic Version]. 2004; NIAAA Newsletter, 3. Retrieved October 16, 2007 from http://pubs.niaaa.nih.gov/ publications/Newsletter/winter2004/Newsletter-Number3.pdf
26. RH Haubrich SJ Little JS Currier DN Forthal CA Kemper GN Beall, et al. 1999 The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response, California Collaborative Treatment Group AIDS 13 9 1099 1107 10.1097/00002030-199906180-00014
27. S Mannheimer G Friedland J Matts C Child M Chesney 2002 The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials Clin Infect Dis 34 8 1115 1121 10.1086/339074
28. A Palepu MW Tyndall R Joy T Kerr E Wood, et al. 2006 Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy Drug and Alcohol Dependence 84 2 188 194 10.1016/j.drugalcdep.2006.02.003